Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week
Published in Oncology

Journal Scan / Research · March 07, 2012

Early or Delayed, Auto-SCT Delivers Comparable Survival in Myeloma

Cancer

 

Additional Info

Disclosure statements are available on the authors' profiles:

Cancer
Early Versus Delayed Autologous Transplantation After Immunomodulatory Agents-Based Induction Therapy in Patients With Newly Diagnosed Multiple Myeloma
Cancer 2012 Mar 01;118(6)1585-1592, SK Kumar, MQ Lacy, A Dispenzieri, MA Gertz, et al

Further Reading